Here's how much Baxalta's chief made last year

By Kristen Schorsch, Crain's Chicago Business  |  March 04, 2016

Baxalta President and CEO Ludwig Hantson received almost $19 million in 2015 for running a company that was not even a year old.

Baxter cutting 1,400 jobs worldwide

By Crain's Chicago Business  |  October 27, 2015

Baxter International said Tuesday that it's cutting about 1,400 jobs worldwide. The cuts represent 5% of the Deerfield, Ill.-based company's non-manufacturing payroll.

Devicemakers step up lobbying to kill ACA tax

Devicemakers step up lobbying to kill ACA tax

By Paul Demko  |  March 07, 2015

While most healthcare stakeholders have slowed their spending on Washington lobbying, one sector has cranked up the pressure—the medical-device industry.

Baxter Q3 net income falls amid strong demand for home kidney-care products

By John N. Frank  |  October 16, 2014

Drug and medical-device maker Baxter International reported a 17% rise it its third-quarter medical products sales, a division that includes home renal-care products that are seeing brisk demand. But those strong medical product sales weren't enough to lift overall Baxter net income for the quarter.

Shortage of in-home dialysis solution has patients worried

By Los Angeles Times  |  September 15, 2014

Baxter International, the nation's leading supplier of peritoneal dialysis solution, says it can't keep up with demand and has started rationing the product, directing physicians to limit the number of new patients to whom they prescribe the treatment and reducing the size of shipments sent to...

Saline solution shortage likely to stretch into 2015

Saline solution shortage likely to stretch into 2015

By Jaimy Lee  |  May 14, 2014

Shortages of IV saline solution may continue through early next year.That's according to John Thompson, vice president of sourcing operations for Novation's medical, surgical and distribution businesses. Novation is a large, privately held group-purchasing organization based in Irving, Texas.

Baxter settles class-action suit for $64 million, denies wrongdoing

Baxter settles class-action suit for $64 million, denies wrongdoing

By Andrew L. Wang, Crain's Chicago Business  |  April 21, 2014

Baxter International agreed to pay $64 million to settle a class-action lawsuit that alleged the Deerfield, Ill.-based company and some of its competitors colluded to raise prices of plasma-based therapies.

Baxter to split into two companies

By Kristen Schorsch and Todd J. Behme, Crain's Chicago Business  |  March 27, 2014

Baxter International said today it plans to split into two companies: one for developing and marketing biopharmaceuticals, and one for medical products.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.